AboutTermsPrivacyContact
 
Updating
Type 2 Diabetes: What’s new in the RACGP guidelines?

Type 2 Diabetes: What’s new in the RACGP guidelines?

Released: 2021-08-23
Type 2 Diabetes: What’s new in the RACGP guidelines? - QR Code
6 Episodes
Audio
Listen on Apple Podcasts
6 Episodes
Audio
Listen on Apple Podcasts
Released: 2021-08-23
Most Recent Episode
Refreshing Key Concepts in Type 2 Diabetes

Refreshing Key Concepts in Type 2 Diabetes

Contributors to the RACGP guidelines, Dr Gary Deed (GP) and Michelle Robins (credentialled diabetes educator and nurse practitioner) along with endocrinologist Dr Tom Dover summarise why the updated guidelines were needed. Together, they consider the...
Time: 14:27
Contributors to the RACGP guidelines, Dr Gary Deed (GP) and Michelle Robins (credentialled diabetes educator and nurse practitioner) along with endocrinologist Dr Tom Dover summarise why the updated guidelines were needed. Together, they consider the goals of therapy, what is meant by ‘patient-centred care’ and how it can be applied in routine clinical practice.
This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi.
References:  1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020.
Episode ID: 1000532747924
GUID: e824884b-325e-4bdd-a337-e5ce6c433c40
Release Date: 23/08/2021, 03:30:00

Description

The updated Royal Australian College of General Practitioners (RACGP) guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence. Across six webinars, contributors to the guidelines, Dr Gary Deed (GP), and Michelle Robins (nurse practitioner and credentialled diabetes educator) are joined by Dr Tom Dover (endocrinologist) to discuss key updates as they share their unique insights and practical guidance on the management of type 2 diabetes.
This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi.
Sanofi‐Aventis Australia Pty Ltd trading as Sanofi Genzyme. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2101753 Date of preparation August 2021

Apple Podcasts: Customer Reviews

No Entry